Gene · 1855
Papers1,433
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,433
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases. | Front Cell Dev Biol | 2023 | 37791070 | PubTator, text mining | PubMed |
| HCMV UL8 interaction with β-catenin and DVL2 regulates viral reactivation in CD34+ hematopoietic progenitor cells. | J Virol | 2023 | 37772824 | PubTator, text mining | PubMed |
| WNT pathway in focal cortical dysplasia compared to perilesional nonlesional tissue in refractory epilepsies. | BMC Neurol | 2023 | 37749503 | PubTator, text mining | PubMed |
| Transcriptome analysis of six tissues obtained post-mortem from sepsis patients. | J Cell Mol Med | 2023 | 37731199 | PubTator, text mining | PubMed |
| CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs. | J Exp Clin Cancer Res | 2023 | 37723588 | PubTator, text mining | PubMed |
| Micro-Executor of Natural Products in Metabolic Diseases. | Molecules | 2023 | 37687031 | PubTator, text mining | PubMed |
| Therapeutic potential of Coptis chinensis for arthritis with underlying mechanisms. | Front Pharmacol | 2023 | 37637408 | PubTator, text mining | PubMed |
| Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression. | EXCLI J | 2023 | 37636026 | PubTator, text mining | PubMed |
| Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway. | Genes Genomics | 2023 | 37634232 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways. | Int J Mol Sci | 2023 | 37629148 | PubTator, text mining | PubMed |
| Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance. | Front Pharmacol | 2023 | 37601042 | PubTator, text mining | PubMed |
| Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review). | Int J Mol Med | 2023 | 37594127 | PubTator, text mining | PubMed |
| An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity. | Dis Model Mech | 2023 | 37589075 | PubTator, text mining | PubMed |
| Recent advances microRNAs and metabolic reprogramming in colorectal cancer research. | Front Oncol | 2023 | 37576895 | PubTator, text mining | PubMed |
| Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease. | Front Immunol | 2023 | 37564637 | PubTator, text mining | PubMed |
| WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. | Diseases | 2023 | 37489441 | PubTator, text mining | PubMed |
| Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling. | Hepatol Commun | 2023 | 37486965 | PubTator, text mining | PubMed |
| Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals. | Nat Commun | 2023 | 37474567 | PubTator, text mining | PubMed |
| Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446204 | PubTator, text mining | PubMed |
| Reconstitution of ATP-dependent lipid transporters: gaining insight into molecular characteristics, regulation, and mechanisms. | Biosci Rep | 2023 | 37417269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1855/papers?page=5